Physician profile
William Gotsis
NPI 1215921606
$7,300.57
in general payments reported to CMS, 2019-2025
34 companies · $775 in 2025
The $775 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2020: $539 · 2021: $942 · 2022: $1,048 · 2023: $1,011 · 2024: $1,759 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,544.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,360.50 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Mylux Patient Kit With Mobile Device |
| Abbott Laboratories | $1,271.94 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Perclose Prostyle, Diamondback Peripheral |
| Medtronic, INC. | $1,108.28 | 2021-2025 | Symplicity G3, Abre, Micra |
| Amgen INC. | $446.12 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $436.19 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $407.79 | 2019-2025 | Farxiga |
| Abiomed | $369.98 | 2020-2025 | Impella |
| Janssen Pharmaceuticals, INC | $340.03 | 2019-2021 | |
| Shockwave Medical, INC | $325.87 | 2022-2025 | |
| Karl Storz Endoscopy-America | $147.72 | 2023 | |
| Edwards Lifesciences Corporation | $130.18 | 2024 | Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals International, Plc | $122.99 | 2024 | Arcalyst |
| Cardiovascular Systems INC. | $121.44 | 2022-2023 | Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.05 | 2024-2025 | Lifevest |
| Cardiva Medical, INC. | $88.14 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $77.17 | 2022-2023 | Optimizer |
| Penumbra, INC. | $56.20 | 2021-2024 | Indigo System |
| Lexicon Pharmaceuticals, INC. | $53.06 | 2023-2024 | Inpefa |
| Philips North America LLC | $37.12 | 2019-2020 | |
| Elutia, INC. | $35.77 | 2022 | |
| Stryker Corporation | $28.54 | 2024 | 1788 |
| Chiesi USA, INC. | $23.31 | 2024 | Kengreal |
| Medtronic Vascular, INC. | $22.13 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $20.00 | 2025 | Opsumit |
| Acist Medical Systems, INC. | $19.42 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.99 | 2022 | |
| Esperion Therapeutics, INC. | $18.86 | 2024 | Nexletol |
| Cagent Vascular INC | $18.38 | 2024 | Serrantor |
| Terumo Medical Corporation | $18.24 | 2023 | Glidewire |
| Amarin Pharma, INC. | $18.13 | 2019 | |
| Cordis US Corp. | $16.99 | 2023 | Mynxgrip |
| Imperative Care, INC | $14.49 | 2025 | Symphony Catheter |
| Biotronik INC. | $14.20 | 2019 | |
| Spectrawave, INC | $12.35 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gotsis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.